These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18539101)

  • 21. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
    Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of degradation products in stressed tablets of Rabeprazole sodium by HPLC-hyphenated techniques.
    Vasu Dev R; Sai Uday Kiran G; Venkata Subbaiah B; Suresh Babu B; Moses Babu J; Dubey PK; Vyas K
    Magn Reson Chem; 2009 May; 47(5):443-8. PubMed ID: 19173350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification, isolation, and characterization of potential degradation products in a triple combination lamivudine, zidovudine, and nevirapine tablet for oral suspension.
    Aparna P; Rao SV; Thomas KM; Mukkanti K; Badarinadh Gupta P; Rangarao K; Narayan GK; Sandip T; Upendra K
    Pharmazie; 2010 May; 65(5):331-5. PubMed ID: 20503923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of four new degradation products of epirubicin through forced degradation, LC-UV, MSn and LC-MS-TOF studies.
    Kaushik D; Saini B; Bansal G
    J Chromatogr Sci; 2015; 53(10):1737-48. PubMed ID: 26162378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study.
    Nageswara Rao R; Narasa Raju A; Narsimha R
    J Pharm Biomed Anal; 2008 Feb; 46(3):505-19. PubMed ID: 18162355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of potential impurities of rabeprazole sodium.
    Reddy GM; Bhaskar BV; Reddy PP; Sudhakar P; Babu JM; Vyas K; Reddy PR; Mukkanti K
    J Pharm Biomed Anal; 2007 Mar; 43(4):1262-9. PubMed ID: 17134865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation, identification and characterization of degradant impurities in Tolterodine tartrate formulation.
    Prakash L; Himaja M; Subbaiah BV; Vasudev R; Srinivasulu C; Haribabu R
    J Pharm Biomed Anal; 2014 Mar; 90():215-21. PubMed ID: 24384498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of potential impurities of donepezil.
    Krishna Reddy KV; Moses Babu J; Kumar PA; Chandrashekar ER; Mathad VT; Eswaraiah S; Reddy MS; Vyas K
    J Pharm Biomed Anal; 2004 Sep; 35(5):1047-58. PubMed ID: 15336352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and identification of five impurities of ALB 109564(a) drug substance.
    Milanowski DJ; Keilman J; Guo C; Mocek U
    J Pharm Biomed Anal; 2011 May; 55(2):366-72. PubMed ID: 21353428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and identification of a new impurity in lorazepam substance.
    Cepanec I; Mikuldas H; Litvić M; Vukusić I
    Pharmazie; 2001 Nov; 56(11):857-9. PubMed ID: 11817169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification, characterization and synthesis of impurities of zafirlukast.
    Goverdhan G; Reddy AR; Srinivas K; Himabindu V; Reddy GM
    J Pharm Biomed Anal; 2009 May; 49(4):895-900. PubMed ID: 19231127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMR and mass spectrometric characterization of vinblastine, vincristine and some new related impurities--part II.
    Háda V; Dubrovay Z; Lakó-Futó A; Galambos J; Gulyás Z; Aranyi A; Szántay C
    J Pharm Biomed Anal; 2013 Oct; 84():309-22. PubMed ID: 23177164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
    Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
    J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of impurities in docetaxel.
    Vasu Dev R; Moses Babu J; Vyas K; Sai Ram P; Ramachandra P; Sekhar NM; Mohan Reddy DN; Srinivasa Rao N
    J Pharm Biomed Anal; 2006 Feb; 40(3):614-22. PubMed ID: 16330175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterisation of degradant impurities in dipyridamole formulation.
    Venkata Subbaiah B; Sree Ganesh KK; Vamsi Krishna G; Vyas K; Vasu Dev R; Subramanyam Reddy K
    J Pharm Biomed Anal; 2012 Mar; 61():256-64. PubMed ID: 22206889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural characterization of impurities in pioglitazone.
    Kumar YR; Reddy AR; Eswaraiah S; Mukkanti K; Reddy MS; Suryanarayana MV
    Pharmazie; 2004 Nov; 59(11):836-9. PubMed ID: 15587582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist.
    Sampath A; Reddy AR; Yakambaram B; Thirupathi A; Prabhakar M; Reddy PP; Reddy VP
    J Pharm Biomed Anal; 2009 Oct; 50(3):405-12. PubMed ID: 19560892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of impurity profiles of Orlistat pharmaceutical products using HPLC tandem mass spectrometry.
    Schneider A; Wessjohann LA
    J Pharm Biomed Anal; 2010 Nov; 53(3):767-72. PubMed ID: 20570457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multidisciplinary approach to identify a degradation product in a pharmaceutical dosage form.
    Pan C; Guan J; Lin M
    J Pharm Biomed Anal; 2011 Mar; 54(4):855-9. PubMed ID: 21129882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation, identification and characterization of novel process-related impurities in flupirtine maleate.
    Zhang D; Song X; Su J
    J Pharm Biomed Anal; 2014 Mar; 90():27-34. PubMed ID: 24333703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.